Results 211 to 220 of about 2,423,583 (291)

Ten simple rules on how to set up an Innovation Boot Camp for exploitation of research results. [PDF]

PLoS Comput Biol
Hollmann S, Hollmann C, Tobin de Fuentes L, Rodriguez SR, Fredes Y, Garcia-Moyano A, Rørvik C, Regierer B.   +7 more
europepmc   +1 more source

Voluntary salt reduction by food companies in Japan: a practical guide to target-setting and reformulation strategies. [PDF]

Hypertens Res
Ikeda N, Yamaguchi M, Kashino I, Miura K, Nishi N.   +4 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Navigating challenges and opportunities: a SWOT analysis of digital management center implementation in county hospitals. [PDF]

Front Public Health
Zhou S, Yin H.
europepmc   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

A multi-stakeholder fuzzy best-worst method analysis of key factors in remanufacturing production processes. [PDF]

Sci Rep
Gao CM, Wong KY, Mohd Maulana MII.
europepmc   +1 more source

Business plans

Roadmap for further exploitation of QROWD results.
openaire   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Identifying Online Only Delivery Food Outlets in the North of England Using Data from Food Delivery Apps

Groves H, Clarkson D, Boyland E, Shaw N, Lake AA, Bradford C, Chang M, Townshend T, Lloyd S, Tindall E, O’Malley C, Moore HJ, Brown H.   +12 more
europepmc   +1 more source